Radial Access for Abdominopelvic Vascular Intervention

RecruitingOBSERVATIONAL
Enrollment

1,143

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
Vascular Access Device Complications
Interventions
PROCEDURE

abdominopelvic vascular intervention through the radial artery access

"According to the pathological changes and needs of the subjects (any abdominal and pelvic arterial intervention that can be performed through the radial artery access, including but not limited to:~1. hepatic intervention, such as transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), etc.;~2. Other visceral intervention, such as spleen, kidney, mesentery, etc.;~3. Pelvic intervention, such as uterine artery embolism, prostatic artery embolism, etc.;~4. Others, such as preoperative embolization of bone tumors (lumbar, sacral vertebra), etc."

Trial Locations (1)

Unknown

RECRUITING

Zhongda Hospital Southeast University, Nanjing

All Listed Sponsors
collaborator

Terumo Medical Corporation

INDUSTRY

lead

Zhongda Hospital

OTHER